Clinical Trials
The 2026 Obesity Power Rankings: Which Pharma Giants Can Break the Lilly-Novo Duopoly?
With the obesity market projected to exceed $130 billion by 2034, we analyze the top 10 pharmaceutical companies vying for dominance. Explore our comprehensive Power Rankings assessing pipeline depth, clinical differentiation, and commercial infrastructure.
Industry
Viewpoint: Why Ireland’s Pharma Sector is Immune to the Global 'Carbon Leakage' Exodus
A new Central Bank of Ireland study reveals that while global manufacturers flee strict climate laws, Ireland's biopharma sector remains stubbornly rooted. Here is what this means for the future of Irish FDI.
Clinical Trials
Helus Pharma Secures US$50M Offering as MDD Trial Surpasses 86% Enrollment
Helus Pharma announces a $50 million offering to progress Phase 3 trials for their novel serotonergic agonists, alongside major clinical milestones and leadership updates.
Industry
NICE Recommends Libtayo for Advanced Cervical Cancer in England and Wales
Around 90 women with advanced cervical cancer in the UK could be eligible for treatment with Regeneron's immunotherapy Libtayo each year, following a green light from NICE.
Industry
Irish Universities Association Launches Strategy 2026-2030 to Navigate Technological and Global Shifts
The IUA has unveiled its ambitious five-year strategy, built around five core priorities: Advocacy, Alignment, Agility, Access, and Accountability, aimed at securing the future of Ireland's higher education sector.
MedTech
Leading Digital Transformation in Ireland’s Pharma Sector: 5 Ways to Overcome Middle Management Resistance to AI
As Ireland’s pharma sector pivots toward Industry 4.0, middle management resistance to AI is a critical bottleneck. Here are 5 root causes of this pushback and targeted strategies to align your teams and drive digital transformation.
MedTech
How to Overcome Middle Management Resistance to AI in Ireland’s Pharma Sector: 5 Root Causes and Targeted Interventions
Middle managers stall more AI rollouts than bad technology does. Here are the 5 root causes of that resistance and the interventions that convert it to active advocacy within 90 days-specifically tailored for Ireland’s thriving Pharmaceutical and MedTech sectors.
Industry
Bridging the Gap: How WorkEqual is Empowering Women and Driving Workplace Equity in Ireland
An in-depth look at WorkEqual, its mission to help women (re)enter the Irish workforce, its national advocacy for gender parity, and the new WorkAbility Programme supporting people with disabilities.
Biotechnology
A Biotech Buying Frenzy: Inside the H1 2026 Pharma M&A Surge
An in-depth analysis of the massive wave of pharmaceutical mergers and acquisitions in the first half of 2026, driven by patent cliffs, pipeline replenishment, and high-growth therapeutic areas.
Pharmaceutical
The Innovation Exodus: Why Europe Must Rethink Medicine Pricing or Risk Losing Life Science Investments
An in-depth analysis of the warnings from pharmaceutical lobby chief Stefan Oelrich regarding European cost-cutting reforms, global pricing shifts, and the threat to clinical research and manufacturing.
Pharmaceutical
Scaling Ireland’s Biopharma Leadership: Inside Eli Lilly’s $2.8 Billion Manufacturing Expansion in Limerick and Kinsale
An in-depth analysis of Eli Lilly’s massive manufacturing footprint in Limerick and Kinsale, highlighting local jobs, high-tech biologic drug production, and Ireland’s strategic position in the global biopharma supply chain.
Pharmaceutical
Roche Seeks Buyer for Former Manufacturing Site in Clarecastle, Co Clare - €4m Price Tag
Swiss pharma giant Roche has appointed Cushman & Wakefield to sell its 88-acre decommissioned manufacturing facility in Clarecastle, Co Clare, with an expected asking price of €4 million, following a €150m remediation programme.